You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

VESPRIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Vesprin patents expire, and what generic alternatives are available?

Vesprin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in three NDAs.

The generic ingredient in VESPRIN is triflupromazine. There are two drug master file entries for this compound. Additional details are available on the triflupromazine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VESPRIN?
What are the global sales for VESPRIN?
What is Average Wholesale Price for VESPRIN?

Summary for VESPRIN

US Patents:	0
Applicants:	2
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	29
Patent Applications:	3,472
DailyMed Link:	VESPRIN at DailyMed

Drug patent expirations by year for VESPRIN

US Patents and Regulatory Information for VESPRIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	VESPRIN	triflupromazine hydrochloride	INJECTABLE;INJECTION	011325-005	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	VESPRIN	triflupromazine hydrochloride	TABLET;ORAL	011123-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	VESPRIN	triflupromazine	SUSPENSION;ORAL	011491-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	VESPRIN	triflupromazine hydrochloride	INJECTABLE;INJECTION	011325-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	VESPRIN	triflupromazine hydrochloride	INJECTABLE;INJECTION	011325-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	VESPRIN	triflupromazine hydrochloride	TABLET;ORAL	011123-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.